What Is Intravenous Immunoglobulin Therapy?
Intravenous Immunoglobulin (IVIG) Therapy is a treatment that involves administering a mixture of antibodies (immunoglobulins) directly into the bloodstream. These antibodies are derived from the plasma of Healthy donors and are used to treat a variety of immune deficiencies, autoimmune diseases, and inflammatory conditions. IVIG works by modulating the immune system, either by enhancing its response to infections or by suppressing abnormal immune activity in autoimmune diseases. Common conditions treated with IVIG include primary immunodeficiency disorders, Guillain-Barr syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and myasthenia gravis.
The Therapy is typically administered in a clinical setting over several hours, with the frequency of treatments ranging from monthly to bi-monthly, depending on the condition and patient response. IVIG is generally well-tolerated, but potential side effects can include headaches, fever, chills, and allergic reactions. Close monitoring during and after the infusion is essential to manage any adverse effects promptly. IVIG can significantly improve the quality of life for patients with certain immune-related conditions by reducing the frequency and severity of infections and controlling autoimmune symptoms.
